This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Scotts Miracle-Gro Upsizes & Prices Senior Notes Due 2029
by Zacks Equity Research
Scotts Miracle-Gro (SMG) is expected to utilize the net proceeds from the offering to redeem all of its outstanding 6% senior notes due 2023.
Cannabis Industry to Scale New Highs Amid Legalization Woes
by Nilanjan Gupta
Legalization will likely drive commercial distribution of cannabis and boost growth of companies operating in this space.
Buy Aurora Cannabis (ACB) Stock Before Earnings, Despite Marijuana Volatility?
by Benjamin Rains
Despite growing sales and wider legalization, many pot stocks have been insanely volatile as Wall Street and investors try to wrap their heads around the marijuana industry. So should you think about buying "cheap" Aurora Cannabis (ACB) Stock before Q4 earnings?
The Zacks Analyst Blog Highlights: FTI, Keysight, NewMarket, Pilgrim's Pride and The Scotts Miracle-Gro
by Zacks Equity Research
The Zacks Analyst Blog Highlights: FTI, Keysight, NewMarket, Pilgrim's Pride and The Scotts Miracle-Gro
5 Top Growth Stocks for September to Ride on Market Rally
by Nalak Das
The U.S. economy is likely to maintain its long-term growth albeit at a slow pace. Several stimulus measures across the globe will also help the U.S. economy to remain stable.
Scotts Miracle-Gro (SMG) Stock Up 16% in 3 Months: Here's Why
by Zacks Equity Research
Better-than-expected Q3 results, upbeat view as well as bright prospects in the Hawthorne unit are driving Scotts Miracle-Gro's (SMG) shares.
Scotts (SMG) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
Scotts (SMG) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Why Scotts Miracle-Gro is Worth Adding to Your Portfolio Now
by Zacks Equity Research
Strong Q3 results, upward estimate revision and upbeat outlook makes Scotts Miracle-Gro (SMG) an appropriate investment option at the moment.
Delta and Scotts Miracle Grow are Aggressive Growth Stocks
by Brian Bolan
A look at two stocks for your aggressive growth stock radar screen
Scotts Miracle-Gro (SMG) Tops Q3 Earnings & Sales Estimates
by Zacks Equity Research
The Sunlight Supply acquisition drives Scotts Miracle-Gro's (SMG) Hawthorne segment in Q3.
Why Scotts Miracle-Gro (SMG) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Scotts Miracle-Gro (SMG) have what it takes? Let's find out.
Scotts Miracle-Gro (SMG) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Scotts (SMG) delivered earnings and revenue surprises of 14.76% and 9.81%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Will Hawthorne Drive Scotts Miracle-Gro's (SMG) Q3 Earnings?
by Zacks Equity Research
Scotts Miracle-Gro (SMG) is witnessing strong growth in the Hawthorne unit, which will likely continue in Q3.
Scotts Miracle-Gro (SMG) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Scotts Miracle-Gro (SMG) have what it takes to be a top stock pick for momentum investors? Let's find out.
Scotts Miracle-Gro (SMG) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Scotts (SMG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Scott's Miracle Grow's, ADT, Innovative Industrial Properties and GW Pharmaceuticals highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Scott's Miracle Grow's, ADT, Innovative Industrial Properties and GW Pharmaceuticals highlighted as Zacks Bull and Bear of the Day
Are You Looking for a High-Growth Dividend Stock? Scotts Miracle-Gro (SMG) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Scotts Miracle-Gro (SMG) have what it takes? Let's find out.
Bull of the Day: Scott's Miracle Grow (SMG)
by David Borun
This well-known maker of lawn and garden supplies also has excellent exposure to the cannabis industry
Bull of the Day: Scotts MiracleGro
by David Borun
This well-known maker of lawn and garden supplies also has excellent exposure to the cannabis industry
Legal Cannabis Faces Competition from Black Market: 3 Stocks That Can Lead the Brigade
by Christopher Vargas
The recent legalization of marijuana in several states in the US has had many people eager to invest in the emerging sector.
The Zacks Analyst Blog Highlights: GW, Scotts Miracle-Gro, Cronos, CannTrust and Canopy
by Zacks Equity Research
The Zacks Analyst Blog Highlights: GW, Scotts Miracle-Gro, Cronos, CannTrust and Canopy
5 Picks Ahead of Key Congressional Hearing on Marijuana Laws
by Nalak Das
Several economists and market researchers believe that the four bills may pave the way for marijuana ETFs, which are likely to attract billions of dollars in investment.
Scotts Miracle-Gro Hits 52-Week High: What's Driving it?
by Zacks Equity Research
Upbeat outlook for fiscal 2019 is driving Scotts Miracle-Gro's (SMG) shares.
Scotts Miracle-Gro (SMG) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Scotts Miracle-Gro (SMG) have what it takes? Let's find out.
The Zacks Analyst Blog Highlights: Canopy Growth, GW, Scotts Miracle-Gro, Cronos and Aurora
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Canopy Growth, GW, Scotts Miracle-Gro, Cronos and Aurora